MD2188G2 - Метод лечения эпилепсии - Google Patents

Метод лечения эпилепсии Download PDF

Info

Publication number
MD2188G2
MD2188G2 MDA20030064A MD20030064A MD2188G2 MD 2188 G2 MD2188 G2 MD 2188G2 MD A20030064 A MDA20030064 A MD A20030064A MD 20030064 A MD20030064 A MD 20030064A MD 2188 G2 MD2188 G2 MD 2188G2
Authority
MD
Moldova
Prior art keywords
epilepsy treatment
treatment
lydase
antiepileptic
neurology
Prior art date
Application number
MDA20030064A
Other languages
English (en)
Romanian (ro)
Other versions
MD2188F1 (en
Inventor
Олег КОБЫЛЯНСКИ
Original Assignee
Олег КОБЫЛЯНСКИ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег КОБЫЛЯНСКИ filed Critical Олег КОБЫЛЯНСКИ
Priority to MDA20030064A priority Critical patent/MD2188G2/ru
Publication of MD2188F1 publication Critical patent/MD2188F1/xx
Publication of MD2188G2 publication Critical patent/MD2188G2/ru

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к медицине, в частности к неврологии, и может быть использовано для лечения больных эпилепсией.Сущность изобретения заключается в том, что вводят противоэпилептические препараты и дополнительно осуществляют электрофорез раствора лидазы в дозе 64 УЕ в область глаз 1 раз в день, на курс 8...10 сеансов.
MDA20030064A 2003-02-28 2003-02-28 Метод лечения эпилепсии MD2188G2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030064A MD2188G2 (ru) 2003-02-28 2003-02-28 Метод лечения эпилепсии

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030064A MD2188G2 (ru) 2003-02-28 2003-02-28 Метод лечения эпилепсии

Publications (2)

Publication Number Publication Date
MD2188F1 MD2188F1 (en) 2003-06-30
MD2188G2 true MD2188G2 (ru) 2003-12-31

Family

ID=19740095

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030064A MD2188G2 (ru) 2003-02-28 2003-02-28 Метод лечения эпилепсии

Country Status (1)

Country Link
MD (1) MD2188G2 (ru)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Oprea N., Nacu A., Revenco M. Psihiatrie. Chişinău, 1994, p. 110-111 *
Верещагин Н. В. и др. Справочник по неврологии. Москва, Медицина, 1989, с. 423 *

Also Published As

Publication number Publication date
MD2188F1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
IL171607A (en) Use of botulinum toxin for the treatment of sinusitis-induced headaches
CR8380A (es) Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos
NZ790449A (en) Treatment of fabry disease in ert-naïve and ert-experienced patients
HK1202776A1 (en) Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
EA201890182A1 (ru) Терапевтическое средство для лечения синдрома гунтера и способ его лечения
EP4230197A3 (en) High concentration medicant solutions for treating neurological disorders
TW200630089A (en) Treatment methods
WO2003057162A3 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
MX2019008076A (es) Regimen terapeutico para el tratamiento de fabry usando alfa-galactosidasa estabilizada.
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
MD2188G2 (ru) Метод лечения эпилепсии
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
BRPI0412506A (pt) células autólogas que induzem à autotoleráncia de origem monocìtica e seu uso em preparações farmacêuticos
EP4374918A3 (en) Methods of treating fabry patients having renal impairment
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
WO2019152343A8 (en) Methods of desensitizing against infusion associated reactions in lysosomal acid lipase deficiency (lal-d) patients treated with exogenous lysosomal acid lipase (lal)
WO2018136647A3 (en) Therapeutic use of beta-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels
RU2002113429A (ru) Способ лечения псориаза
Suter-Montano Molgramostim/peginterferon-α-2a
WO2003055411A3 (de) Implantierbare vorrichtung und deren verwendung

Legal Events

Date Code Title Description
MM4A Patent for invention definitely lapsed due to non-payment of fees